0.7310
-0.0471
(-6.05%)
At close: January 10 at 4:00:02 PM EST
0.7344
+0.00
+(0.47%)
After hours: January 10 at 5:43:48 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,863.7410
-15,762.5120
-18,866.8430
-12,827.1170
-8,337.7700
Investing Cash Flow
--
-73.5610
-250.0460
-248.9830
-95.2120
Financing Cash Flow
10,819.9870
-407.1730
-155.5990
49,256.8730
11,106.2780
End Cash Position
6,355.1000
3,367.2290
19,635.7250
38,888.8280
2,691.1560
Interest Paid Supplemental Data
15.0970
27.5090
10.8200
--
--
Capital Expenditure
--
-73.5610
-250.0460
-248.9830
-95.2120
Issuance of Capital Stock
--
--
--
39,797.3770
--
Issuance of Debt
--
--
--
9,459.3460
11,105.3780
Repurchase of Capital Stock
-0.0020
-477.6390
-157.1940
--
--
Free Cash Flow
-10,863.7410
-15,836.0730
-19,116.8890
-13,076.1000
-8,432.9820
12/31/2020 - 10/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AGEN Agenus Inc.
3.1150
-8.38%
KLTO Klotho Neurosciences, Inc.
0.4950
+9.73%
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%
PBLA Panbela Therapeutics, Inc.
0.3700
+2.49%
HOOK HOOKIPA Pharma Inc.
2.1500
+15.59%
AZTR Azitra, Inc.
0.3600
-8.30%
PASG Passage Bio, Inc.
0.6700
+1.67%
NUVB Nuvation Bio Inc.
2.7800
-7.64%
AKTX Akari Therapeutics, Plc
1.2150
-5.08%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%